Abstract
Cogan’s syndrome (CS) is an immune-mediated disease characterized by ocular inflammation and audiovestibular dysfunction with or without vasculitis or other systemic manifestations (1). Audiovestibular disease that is difficult to treat can lead to the loss of hearing (2). By a timely recognition and initiation of glucocorticoid therapy at the onset of the disease, poor outcomes, especially complete hearing loss, could sometimes be prevented (2). Certain patients may require long-term corticosteroid therapy because of recurrent hearing loss during attempts to taper the prednisone dose (3). We report Cogan’s syndrome in a 14 year-old-girl with marked deterioration of hearing power following tapering of corticosteroid therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.